Clinical Trials
at M. D. Anderson Cancer Center
By Cancer Type
What are Clinical Trials?
What are the Phases of Clinical Trials?
Participating in Clinical Trials
Frequently Asked Questions
Clinical Trials at M.D. Anderson
View studies by cancer
type
View studies by treatment
View studies by study
number
View studies by physician
View studies by phase
View studies by NCT number
Completed Clinical Trials at M.D. Anderson
View trials by cancer type
View trials by treatment
View trials by study
number
View trials by physician
View trials by phase
View studies by NCT number
.
.
.
.
.Click on blue triangle to read clinical research studies. Information is displayed as:
Treatment Agent(s)/ Physician/ Study Number.
.

+ Gynecology
Interview, Questionnaire / Charlotte C. Sun / 2003-0529
None / James D. Cox / 2003-0962
None / Lorenzo Cohen / 2004-0024
Cisplatin, Liposomal Doxorubicin / Apostolia M. Tsimberidou / 2004-0568
Paclitaxel / Apostolia M. Tsimberidou / 2005-0092
Adriamycin, AMG 531, Carboplatin, Ifosfamide / Saroj Vadhan-Raj / 2005-0099
None / Judith A. Smith / 2005-0543
None / Pedro Ramirez / 2006-0170
Behavioral Intervention / Leslie R. Schover / 2006-0340
None / Lois M. Ramondetta / 2006-0724
None / Elie Mouhayar / 2006-0921
None / Diane C. Bodurka / 2007-0549
Music Relaxation Video / Grace C. Chi / 2007-0600
None / Karen H. Lu / GOG-0199
Collection, Methotrexate, Dactinomycin / Lois M. Ramondetta / GOG 0174
Treatment information not available / John J. Kavanagh / GOG 0182
Treatment information not available / Charles Levenback / GOG 0206
Questionaire / Diane C. Bodurka / GYNP00-023
Paclitaxel / Anuja Jhingran / ID00-418
None / Cynthia G. Segal / ID01-024
Radiation / Patricia J. Eifel / ID03-0047
None / Susan Peterson / ID03-0211
None / Anuja Jhingran / IDP00-075
None / Karen H. Lu / LAB02-188
Cisplatin, Radiation / Anuja Jhingran / RTOG0418
+ Head And Neck
+ Hematologic Disorder
+ Infection
+ Kidney
.
.
.
.
....
.
.
.
©2009 The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
1-800-392-1611 (USA) / 1-713-792-6161 Legal Statements